![]() |
市场调查报告书
商品编码
1828115
2025年全球内视镜治疗设备市场报告Endotherapy Devices Global Market Report 2025 |
近年来,内视镜治疗设备市场规模强劲成长,从2024年的46.3亿美元增至2025年的48.7亿美元,复合年增长率为5.2%。预测期内的成长可归因于胃肠道疾病盛行率的上升、人口老化、认知度的提高和早期诊断、有利的报销政策、全球经济发展以及策略联盟和伙伴关係。
预计未来几年内视镜治疗设备市场规模将强劲成长,到2029年将达到65.7亿美元,复合年增长率为7.8%。预测期内的成长可归因于微创技术的进步、慢性病负担的增加、医疗基础设施的扩展、对早期检测的重视程度的提高、监管支持和标准化。预测期内的全球趋势包括影像技术的进步、人工智慧的整合、技术进步、医疗基础设施的全球扩张以及胃肠道疾病盛行率的上升。
内视镜设备是用于内视镜检查的医疗器械,旨在诊断、治疗和管理各种医疗领域的各种疾病,包括胃肠道、大肠镜、腹腔镜、关节镜、关节镜和支气管镜。这些医疗设备专门设计用于与内视镜配合使用。内视镜是一种配有光源和摄影机的柔性导管,可帮助医生更有效地直观地检查内臟器官。
内视镜器械的主要类别包括胃肠器械及配件、内视镜逆行性造影器材及配件及其他内视镜器械。胃肠器械及配件是用于诊断和治疗胃肠道 (GI) 疾病的医疗工具。它们在各种手术中发挥重要作用,例如内视镜检查,它可以观察消化道内部,包括食道、胃、十二指肠和大肠。此外,这些器械也用于外科手术,直接向患处提供标靶治疗。这些器械广泛应用于神经科学用内视镜、关节镜、腹腔镜检查、泌尿系统检查、神经内视镜检查、胃肠内视镜检查以及医院、门诊手术中心和其他最终用户执行的其他医疗程序。
2025年春季美国关税突然上调及其引发的贸易摩擦,对医疗设备领域产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了形势,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分,该系列提供内视镜治疗设备的市场统计数据,包括全球市场规模、区域份额、市场份额竞争对手、详细的内视镜治疗设备细分市场、市场趋势和商业机会,以及您在内视镜治疗设备行业取得成功所需的数据。本内视镜治疗设备市场研究报告对该行业的现状和未来趋势进行了详细分析,为您提供所需的一切观点。
未来五年7.8%的预测成长率比我们先前对该市场的预测略有下降,下降了0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这种影响可能会透过对来自法国和荷兰等主要地区的止血夹和内视镜缝合系统征收关税直接影响美国,这可能导致治疗性介入延迟并增加胃肠道消化道出血的治疗成本。由于互惠关税以及不断升级的贸易摩擦和限制对全球经济和贸易的负面影响,这种影响也将更加广泛。
预计未来胃肠道疾病发病率的上升将推动治疗性内视镜市场的成长。消化系统疾病会影响从口腔到肛门的消化道,包括大肠直肠癌、胃食道逆流、溃疡性大肠炎(UC)、发炎性肠道疾病 (IBD) 和克隆氏症(CD) 等疾病。内视镜检查透过非侵入性或微创手术来治疗和诊断胃肠道疾病,解决溃疡、出血、乳糜泻、阻塞、发炎和消化道肿瘤等问题。内视镜检查也有助于找出胃灼热、腹痛、噁心、呕吐和出血等不明原因症状的原因。例如,根据澳洲癌症协会 (Cancer Australia) 的报告,预计 2023 年澳洲将新增 2,576 例胃癌病例,其中包括 1,647 名男性和 929 名女性。 85岁前确诊胃肠道疾病的风险约为1/117(0.85%),其中男性为1/91(1.1%),女性为1/164(0.61%)。因此,胃肠道疾病的盛行率不断上升,推动了内视镜设备市场的成长。
肥胖症盛行率的上升进一步推动了内视镜设备市场的成长。肥胖症的特征是体内多余脂肪的堆积,会对健康产生负面影响,而内视镜设备可以有效控制肥胖。这些设备在减重、减少食慾、改善生活品质、提供微创治疗以及为肥胖管理提供临时干预措施方面发挥着重要作用。根据世界肥胖组织预测,2025年,肥胖人数将增加至8.92亿,2030年将达到10.25亿人。在英国,预计2021年至2022年间,18岁以上族群中25.9%将肥胖。因此,肥胖症的流行是推动内视镜设备市场扩张的主要因素。
内视镜设备市场的主要企业正在开发创新解决方案,例如红二向色成像 (RDI),以提高内视镜检查过程中血管和出血部位的可视化效果。 RDI 利用两种不同波长的光来增强血管和病变的可见性,从而提高检查过程中的诊断准确性。例如,总部位于日本的医疗科技公司奥林巴斯株式会社于 2023 年 10 月推出了 EVIS X1 内视镜系统。这款尖端系统将先进的成像技术与人工智慧相结合,以提高视觉化和诊断能力。 EVIS X1 具有纹理和色彩增强成像 (TXI) 功能,可透过增强色彩和纹理来增强病灶和息肉的可见性。此外,RDI 专注于深层血管和出血部位,而亮度可调且对比度保持的成像 (BAI-MAC) 可确保整个影像的亮度水平均衡。
内视镜治疗设备市场的主要企业正策略性地专注于内视镜系统等创新产品,以推动市场收益。内视镜系统是用于内部器官检查的微创医疗技术。例如,日本光学仪器和影印机製造商奥林巴斯公司于 2023 年 10 月推出了 EVIS X1。该系统配备了红色双色成像 (RDI™) 和纹理和色彩增强成像 (TXIT™) 等尖端成像技术,可增强胃肠道的可视性并识别异常。符合人体工学的握把控制装置重量减轻 10%,操作舒适。 EVIS X1 内视镜系统的推出体现了奥林巴斯致力于推进内视镜技术并向医疗专业人员提供高品质治疗所需工具的承诺。
2024年1月,日本医疗科技公司奥林巴斯株式会社收购了泰熊医疗株式会社。此次收购使奥林巴斯能够透过提供广泛的临床差异化技术,改善患者治疗效果并提升胃肠道护理水平。泰熊医疗株式会社是一家韩国製造商,专门生产包括胃肠道 (GI) 金属支架在内的医疗设备。
内视镜治疗设备市场的主要企业包括奥林巴斯公司、波士顿科学公司、康美德公司、美敦力公司、富士胶片控股公司、强生库克集团公司、Karl Storz SE & Co. KG、史赛克公司、泰熊医疗有限公司、施乐辉公司、Steris 公司、微技术(南京)有限公司、豪雅公司、库克集团有限公司、B. Healthcare、宾得医疗、尼普洛公司、MEDIVATORS BV、美国内视镜集团公司、理查德·沃尔夫有限公司、Cantel Medical Corp.、富士能公司、Gyrus ACMI、Cogentix Medical Inc. 和 Endogastric Solutions Inc.。
2024年,北美将成为内视镜治疗设备市场最大的地区。预计亚太地区将成为预测期内全球内视镜治疗设备市场成长最快的地区。内视镜治疗设备市场报告涵盖亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
内视镜治疗设备市场报告涵盖的国家:澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
内视镜治疗设备市场涵盖机械增强大肠镜、内视镜止血设备、组织取样设备、金属支架、扩张球囊、异物取出设备、电外科手术设备以及UCR充气设备等设备的销售。该市场的价值为“出厂价”,即商品製造商或生产商向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的商品价值。该市场中的商品价值还包括商品製造商提供的任何相关服务。
Endotherapy devices are medical instruments employed in endoscopic procedures aimed at diagnosing, treating, and managing various disorders across different medical fields such as gastrointestinal, colonoscopy, laparoscopy, anoscopy, arthroscopy, bronchoscopy, and others. These devices are specifically designed for use in conjunction with an endoscope, a flexible tube equipped with a light and camera that enables physicians to visually inspect the internal organs more effectively.
The primary categories of endotherapy devices include gastrointestinal devices and accessories, endoscopic retrograde cholangiopancreatography devices and accessories, and other endotherapy devices. Gastrointestinal devices and accessories are medical tools utilized in the diagnosis and treatment of gastrointestinal (GI) disorders. They play a crucial role in various procedures, including endoscopic examinations that allow visualization and access to the inside of the GI tract, covering areas such as the esophagus, stomach, duodenum, and colon. Additionally, these devices are employed in surgical interventions to deliver targeted therapies directly to affected areas. These devices find extensive applications in bronchoscopy, arthroscopy, laparoscopy, urology endoscopy, neuro-endoscopy, gastrointestinal endoscopy, and other medical procedures performed by hospitals, ambulatory surgical centers, and other end-users.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The endotherapy devices market research report is one of a series of new reports from The Business Research Company that provides endotherapy devices market statistics, including endotherapy devices industry global market size, regional shares, competitors with an endotherapy devices market share, detailed endotherapy devices market segments, market trends and opportunities, and any further data you may need to thrive in the endotherapy devices industry. This endotherapy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The endotherapy devices market size has grown strongly in recent years. It will grow from $4.63 billion in 2024 to $4.87 billion in 2025 at a compound annual growth rate (CAGR) of 5.2%. The growth in the historic period can be attributed to the rising prevalence of gastrointestinal disorders, the aging population, increased awareness and early diagnosis, favorable reimbursement policies, global economic development, strategic collaborations and partnerships.
The endotherapy devices market size is expected to see strong growth in the next few years. It will grow to $6.57 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to advancements in minimally invasive techniques, the growing burden of chronic diseases, expansion of healthcare infrastructure, increased focus on early detection, regulatory support and standardization. Major trends in the forecast period include advances in imaging technologies, integration of artificial intelligence, technological advancements, global expansion of healthcare infrastructure, and increased prevalence of gastrointestinal disorders.
The forecast of 7.8% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on hemostasis clips and endoscopic suturing systems, sourced from key regions such as France and the Netherlands, which could lead to delayed therapeutic interventions and higher costs for gastrointestinal bleeding management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of gastrointestinal diseases is projected to drive the growth of the endotherapy devices market in the future. Gastrointestinal illnesses affect the digestive tract from the mouth to the anus and include conditions such as colorectal cancer, gastroesophageal reflux disease, ulcerative colitis (UC), inflammatory bowel disease (IBD), and Crohn's disease (CD). Endotherapy devices are employed in the treatment and diagnosis of gastrointestinal diseases through non-invasive or minimally invasive surgical procedures, addressing issues like ulcers, bleeding, celiac disease, obstructions, inflammation, and tumors within the gastrointestinal tract. They also assist in identifying the source of unexplained symptoms such as heartburn, abdominal pain, nausea, vomiting, and bleeding. For instance, reports from Cancer Australia, an Australian organization, indicate that in 2023, Australia is expected to see 2,576 new cases of stomach cancer, comprising 1,647 in males and 929 in females. The lifetime risk of diagnosis by age 85 is approximately 1 in 117 (0.85%), with males facing a risk of 1 in 91 (1.1%) and females 1 in 164 (0.61%). Therefore, the rising incidence of gastrointestinal diseases is driving growth in the endotherapy devices market.
The growth of the endotherapy devices market is further fueled by the rising prevalence of obesity. Obesity, characterized by the excessive accumulation of body fat with adverse effects on health, can be effectively managed with endotherapy devices. These devices play a crucial role in weight loss, appetite reduction, improving the quality of life, providing minimally invasive treatment, and offering temporary interventions for obesity management. According to World Obesity, the number of obese individuals is expected to increase to 892 million in 2025 and reach 1,025 million in 2030. In England, it was projected that 25.9% of individuals aged 18 and older were obese in 2021-2022. Consequently, the growing prevalence of obesity is a key driver for the expansion of the endotherapy devices market.
Key companies in the endotherapy devices market are developing innovative solutions, such as red dichromatic imaging (RDI), to improve the visualization of blood vessels and bleeding sites during endoscopic procedures. RDI enhances the visibility of blood vessels and lesions by utilizing two different wavelengths of light, which improves diagnostic accuracy during procedures. For example, in October 2023, Olympus Corporation, a medical technology company based in Japan, launched the EVIS X1 endoscopy system. This cutting-edge system integrates advanced imaging technologies and artificial intelligence to enhance visualization and diagnostic capabilities. The EVIS X1 features texture and color enhancement imaging (TXI), which improves the visibility of lesions and polyps by enhancing their color and texture. Additionally, RDI focuses on deep blood vessels and bleeding points, while brightness adjustment imaging with maintenance of contrast (BAI-MAC) ensures balanced brightness levels throughout the image.
Major companies in the endotherapy devices market are strategically focusing on innovative products such as endoscopy systems to drive market revenues. An endoscopy system is a minimally invasive medical technology used for internal organ examination. For example, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, launched EVIS X1 in October 2023. Equipped with cutting-edge imaging technologies such as red dichromatic imaging (RDITM) and texture and color enhancement imaging (TXITM), the system enhances visibility and abnormality identification in the gastrointestinal tract. Notable features include a 10% lighter ErgoGrip control section for improved user comfort and scope handling. The introduction of the EVIS X1 endoscopic system reflects Olympus' commitment to advancing endoscopy technology and providing medical professionals with the tools necessary for high-quality treatment.
In January 2024, Olympus Corporation, a medical technology company based in Japan, acquired Taewoong Medical Co. Ltd. for an undisclosed sum. This acquisition allows Olympus to improve patient outcomes by providing a wider range of clinically differentiated technologies, thereby elevating the standard of care in gastrointestinal treatments. Taewoong Medical Co. Ltd. is a manufacturer located in South Korea that specializes in medical devices, including gastrointestinal (GI) metallic stents.
Major companies operating in the endotherapy devices market include Olympus Corporation, Boston Scientific Corporation, Conmed Corporation, Medtronic Plc, Fujifilm Holdings Corporation, Johnson & JohnsonCook Group Incorporated, Karl Storz SE & Co. KG, Stryker Corporation, Taewoong Medical Co. Ltd, Smith & Nephew Plc., Steris Corporation, Micro-Tech (Nanjing) Co Ltd., HOYA Corporation, Cook Group Incorporated, B. Braun Melsungen AG, Frontier Healthcare, Pentax Medical, Nipro Corporation, MEDIVATORS B.V., US Endoscopy Group Inc., Richard Wolf GmbH, Cantel Medical Corp., Fujinon Corporation, Gyrus ACMI, Cogentix Medical Inc., Endogastric Solutions Inc.
North America as the largest region in the endotherapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global endotherapy devices market report during the forecast period. The regions covered in the endotherapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the endotherapy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The endotherapy devices market consists of sales of devices such as mechanically enhanced colonoscopies, endoscopic hemostasis, tissue sampling devices, metallic stents, dilation balloons, foreign body retrieval devices, electrosurgical needs, and UCR insufflators. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Endotherapy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on endotherapy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for endotherapy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The endotherapy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.